BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 25962958)

  • 21. RASAL2, a RAS GTPase-activating protein, inhibits stemness and epithelial-mesenchymal transition via MAPK/SOX2 pathway in bladder cancer.
    Hui K; Gao Y; Huang J; Xu S; Wang B; Zeng J; Fan J; Wang X; Yue Y; Wu S; Hsieh JT; He D; Wu K
    Cell Death Dis; 2017 Feb; 8(2):e2600. PubMed ID: 28182001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of RAB1B promotes triple-negative breast cancer metastasis by activating TGF-β/SMAD signaling.
    Jiang HL; Sun HF; Gao SP; Li LD; Hu X; Wu J; Jin W
    Oncotarget; 2015 Jun; 6(18):16352-65. PubMed ID: 25970785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipocalin-2 negatively modulates the epithelial-to-mesenchymal transition in hepatocellular carcinoma through the epidermal growth factor (TGF-beta1)/Lcn2/Twist1 pathway.
    Wang YP; Yu GR; Lee MJ; Lee SY; Chu IS; Leem SH; Kim DG
    Hepatology; 2013 Oct; 58(4):1349-61. PubMed ID: 23696034
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Down-regulating ribonuclease inhibitor enhances metastasis of bladder cancer cells through regulating epithelial-mesenchymal transition and ILK signaling pathway.
    Xiong D; Liou Y; Shu J; Li D; Zhang L; Chen J
    Exp Mol Pathol; 2014 Jun; 96(3):411-21. PubMed ID: 24768914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Downregulation of cathepsin L suppresses cancer invasion and migration by inhibiting transforming growth factor‑β‑mediated epithelial‑mesenchymal transition.
    Zhang Q; Han M; Wang W; Song Y; Chen G; Wang Z; Liang Z
    Oncol Rep; 2015 Apr; 33(4):1851-9. PubMed ID: 25632968
    [TBL] [Abstract][Full Text] [Related]  

  • 26. JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells.
    Liu RY; Zeng Y; Lei Z; Wang L; Yang H; Liu Z; Zhao J; Zhang HT
    Int J Oncol; 2014 May; 44(5):1643-51. PubMed ID: 24573038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ACK1 promotes gastric cancer epithelial-mesenchymal transition and metastasis through AKT-POU2F1-ECD signalling.
    Xu SH; Huang JZ; Xu ML; Yu G; Yin XF; Chen D; Yan GR
    J Pathol; 2015 Jun; 236(2):175-85. PubMed ID: 25678401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CX3CL1 increases invasiveness and metastasis by promoting epithelial-to-mesenchymal transition through the TACE/TGF-α/EGFR pathway in hypoxic androgen-independent prostate cancer cells.
    Tang J; Xiao L; Cui R; Li D; Zheng X; Zhu L; Sun H; Pan Y; Du Y; Yu X
    Oncol Rep; 2016 Feb; 35(2):1153-62. PubMed ID: 26718770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of the integrin-linked kinase (ILK)/Rictor complex in TGFβ-1-induced epithelial-mesenchymal transition (EMT).
    Serrano I; McDonald PC; Lock FE; Dedhar S
    Oncogene; 2013 Jan; 32(1):50-60. PubMed ID: 22310280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatoma-derived growth factor regulates breast cancer cell invasion by modulating epithelial--mesenchymal transition.
    Chen SC; Kung ML; Hu TH; Chen HY; Wu JC; Kuo HM; Tsai HE; Lin YW; Wen ZH; Liu JK; Yeh MH; Tai MH
    J Pathol; 2012 Oct; 228(2):158-69. PubMed ID: 22247069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Salinomycin suppresses TGF-β1-induced epithelial-to-mesenchymal transition in MCF-7 human breast cancer cells.
    Zhang C; Lu Y; Li Q; Mao J; Hou Z; Yu X; Fan S; Li J; Gao T; Yan B; Wang B; Song B; Li L
    Chem Biol Interact; 2016 Mar; 248():74-81. PubMed ID: 26896736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ZNF217 is a marker of poor prognosis in breast cancer that drives epithelial-mesenchymal transition and invasion.
    Vendrell JA; Thollet A; Nguyen NT; Ghayad SE; Vinot S; Bièche I; Grisard E; Josserand V; Coll JL; Roux P; Corbo L; Treilleux I; Rimokh R; Cohen PA
    Cancer Res; 2012 Jul; 72(14):3593-606. PubMed ID: 22593193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sohlh2 suppresses epithelial to mesenchymal transition in breast cancer via downregulation of IL-8.
    Ji S; Zhang W; Zhang X; Hao C; Hao A; Gao Q; Zhang H; Sun J; Hao J
    Oncotarget; 2016 Aug; 7(31):49411-49424. PubMed ID: 27384482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TGF-β1 mediates epithelial to mesenchymal transition via the TGF-β/Smad pathway in squamous cell carcinoma of the head and neck.
    Yu C; Liu Y; Huang D; Dai Y; Cai G; Sun J; Xu T; Tian Y; Zhang X
    Oncol Rep; 2011 Jun; 25(6):1581-7. PubMed ID: 21479366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extracellular signal-regulated kinase and Akt activation play a critical role in the process of hepatocyte growth factor-induced epithelial-mesenchymal transition.
    Tanahashi T; Osada S; Yamada A; Kato J; Yawata K; Mori R; Imai H; Sasaki Y; Saito S; Tanaka Y; Nonaka K; Yoshida K
    Int J Oncol; 2013 Feb; 42(2):556-64. PubMed ID: 23229794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epigallocatechin gallate suppresses lung cancer cell growth through Ras-GTPase-activating protein SH3 domain-binding protein 1.
    Shim JH; Su ZY; Chae JI; Kim DJ; Zhu F; Ma WY; Bode AM; Yang CS; Dong Z
    Cancer Prev Res (Phila); 2010 May; 3(5):670-9. PubMed ID: 20424128
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fascin, an actin-bundling protein, promotes breast cancer progression in vitro.
    Xing P; Li JG; Jin F; Zhao TT; Liu Q; Dong HT; Wei XL
    Cell Biochem Funct; 2011 Jun; 29(4):303-10. PubMed ID: 21491467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic depletion and pharmacological targeting of αv integrin in breast cancer cells impairs metastasis in zebrafish and mouse xenograft models.
    Li Y; Drabsch Y; Pujuguet P; Ren J; van Laar T; Zhang L; van Dam H; Clément-Lacroix P; Ten Dijke P
    Breast Cancer Res; 2015 Feb; 17(1):28. PubMed ID: 25849225
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The tumor suppressor Smad4 is required for transforming growth factor beta-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells.
    Deckers M; van Dinther M; Buijs J; Que I; Löwik C; van der Pluijm G; ten Dijke P
    Cancer Res; 2006 Feb; 66(4):2202-9. PubMed ID: 16489022
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An novel inhibitor of TGF-β type I receptor, IN-1130, blocks breast cancer lung metastasis through inhibition of epithelial-mesenchymal transition.
    Park CY; Min KN; Son JY; Park SY; Nam JS; Kim DK; Sheen YY
    Cancer Lett; 2014 Aug; 351(1):72-80. PubMed ID: 24887560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.